ZBH ZIMMER BIOMET HOLDINGS INC revenue, earnings and financials

For the quarter ended June 30, 2026, ZIMMER BIOMET HOLDINGS INC reported revenue of $2.18B (up 4.8% from a year earlier), net income of $198M and diluted EPS of $1.03; over the last four quarters revenue was $8.51B and net income $807M; for the fiscal year ended December 2025 revenue was $8.23B, up 7.2% on the year before.

ZBH annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $8.23B, gross profit n/a, operating income $1.10B, net income $705M (margin 8.6%), EPS $3.55
• Fiscal year ended Dec 2024: revenue $7.68B, gross profit n/a, operating income $1.29B, net income $904M (margin 11.8%), EPS $4.43
• Fiscal year ended Dec 2023: revenue $7.39B, gross profit n/a, operating income $1.28B, net income $1.02B (margin 13.8%), EPS $4.88
• Fiscal year ended Dec 2022: revenue $6.94B, gross profit n/a, operating income $696M, net income $231M (margin 3.3%), EPS $1.10
• Fiscal year ended Dec 2021: revenue $6.83B, gross profit n/a, operating income $860M, net income $402M (margin 5.9%), EPS $1.91

ZBH quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue $2.18B (up 4.8% year over year), net income $198M, EPS $1.03
• Quarter ended Mar 31, 2026: revenue $2.09B (up 9.3% year over year), net income $238M, EPS $1.22
• Quarter ended Dec 31, 2025 (from the annual report): revenue $2.24B (up 10.9% year over year), net income $139M, EPS $0.71
• Quarter ended Sep 30, 2025: revenue $2.00B (up 9.7% year over year), net income $231M, EPS $1.16
• Quarter ended Jun 30, 2025: revenue $2.08B (up 7.0% year over year), net income $153M, EPS $0.77
• Quarter ended Mar 31, 2025: revenue $1.91B (up 1.1% year over year), net income $182M, EPS $0.91
• Quarter ended Dec 31, 2024 (from the annual report): revenue $2.02B (up 4.3% year over year), net income $240M, EPS $1.18
• Quarter ended Sep 30, 2024: revenue $1.82B (up 4.0% year over year), net income $249M, EPS $1.23
• Quarter ended Jun 30, 2024: revenue $1.94B (up 3.9% year over year), net income $243M, EPS $1.18
• Quarter ended Mar 31, 2024: revenue $1.89B (up 3.2% year over year), net income $172M, EPS $0.84
• Quarter ended Dec 31, 2023 (from the annual report): revenue $1.94B (up 6.3% year over year), net income $419M, EPS $2.00
• Quarter ended Sep 30, 2023: revenue $1.75B (up 5.0% year over year), net income $163M, EPS $0.77
• Quarter ended Jun 30, 2023: revenue $1.87B (up 4.9% year over year), net income $210M, EPS $1.00
• Quarter ended Mar 31, 2023: revenue $1.83B (up 10.1% year over year), net income $233M, EPS $1.11
• Quarter ended Dec 31, 2022 (from the annual report): revenue $1.83B (up 2.7% year over year), net income −$131M, EPS −$0.62
• Quarter ended Sep 30, 2022: revenue $1.67B (down 0.9% year over year), net income $194M, EPS $0.92
• Quarter ended Jun 30, 2022: revenue $1.78B (up 1.0% year over year), net income $154M, EPS $0.73
• Quarter ended Mar 31, 2022: revenue $1.66B (up 3.9% year over year), net income $14.2M, EPS $0.07
• Quarter ended Dec 31, 2021 (from the annual report): revenue $1.78B, net income −$84.0M, EPS −$0.39
• Quarter ended Sep 30, 2021: revenue $1.69B, net income $146M, EPS $0.69

ZBH cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow $1.70B, share buybacks $487M, dividends $0.96 per share
• Fiscal year ended Dec 2024: operating cash flow $1.50B, share buybacks $868M, dividends $0.96 per share
• Fiscal year ended Dec 2023: operating cash flow $1.58B, share buybacks $692M, dividends $0.96 per share
• Fiscal year ended Dec 2022: operating cash flow n/a, share buybacks $126M, dividends $0.96 per share
• Fiscal year ended Dec 2021: operating cash flow $1.50B, share buybacks n/a, dividends $0.96 per share

ZBH balance sheet

• Jun 30, 2026: cash $410M, total assets $22.8B, total liabilities $10.2B, shareholders' equity $12.6B, long-term debt $6.28B
• Mar 31, 2026: cash $424M, total assets $22.7B, total liabilities $10.0B, shareholders' equity $12.7B, long-term debt $6.30B
• Dec 31, 2025: cash $592M, total assets $23.1B, total liabilities $10.4B, shareholders' equity $12.7B, long-term debt $6.93B
• Sep 30, 2025: cash $1.29B, total assets $23.5B, total liabilities $10.7B, shareholders' equity $12.8B, long-term debt $7.51B
• Jun 30, 2025: cash $557M, total assets $22.9B, total liabilities $10.3B, shareholders' equity $12.5B, long-term debt $6.75B
• Mar 31, 2025: cash $1.38B, total assets $22.2B, total liabilities $9.78B, shareholders' equity $12.4B, long-term debt $6.58B
• Dec 31, 2024: cash $526M, total assets $21.4B, total liabilities $8.89B, shareholders' equity $12.5B, long-term debt $5.34B
• Sep 30, 2024: cash $569M, total assets $21.7B, total liabilities $9.34B, shareholders' equity $12.4B, long-term debt $4.74B

What is ZBH's revenue?

ZIMMER BIOMET HOLDINGS INC reported $8.51B of revenue over its last four quarters, through June 30, 2026.

Is ZBH profitable?

Yes. ZIMMER BIOMET HOLDINGS INC earned $807M over the last four quarters.

What is ZBH's EPS?

Diluted earnings per share over the last four quarters were $4.12; $1.03 in the latest quarter.

Does ZBH pay a dividend?

ZIMMER BIOMET HOLDINGS INC paid $0.96 per share in dividends in the fiscal year ended December 2025.

ZBH ownership and insider trades · All stocks